A phase I study of DTGM fusion protein (IND BB-8153) [DT GM CSF] in relapsed and refractory adult acute myeloid leukemia (AML)
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2017
At a glance
- Drugs DT GM CSF (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 11 Oct 2005 New trial record.